| 生物活性 | |||
|---|---|---|---|
| 靶点 |
|
||
| 描述 | Fisogatinib, also known as BLU-554, is a strong, highly selective, and orally bioavailable inhibitor of FGFR4, exhibiting IC50 value of 5 nM. It demonstrates considerable efficacy against tumors in hepatocellular carcinoma (HCC) models that rely on FGFR4 signaling[1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
1.99mL 0.40mL 0.20mL |
9.93mL 1.99mL 0.99mL |
19.87mL 3.97mL 1.99mL |
| 参考文献 |
|---|